A member of the Royal Institute of Chartered Surveyors, Damian has an extensive background in real estate investment. He is also father to a 13-year-old son, Darragh, who lives with autism and has epilepsy. Damian and his wife Fiona have been using CBD oil to help successfully control Darragh’s seizures since January 2017.

An advocate of the research, development and prescription of medical cannabis, Damian was extensively involved in the patient-led campaigns for the UK government to reschedule cannabis-based products for medicinal use in 2018.

In 2019, Damian co-founded Kingdom Therapeutics, a team of leading experts in the pharmaceutical industry, pharmaceutical development, the science of cannabinoids, healthcare and pharmaceutical intellectual property. Kingdom Therapeutics is developing a novel cannabinoid-based medicine to help improve the lives of children living with Autism Spectrum Disorder. Kingdom’s groundbreaking science explores the role of the gut-brain-endocannabinoid axis in profound autism, and currently, their team are investigating if their first product candidate, the cannabinoid-based treatment KT-20610, can improve both behavioural and gastrointestinal symptoms in ASD.